Dr. Joseph Grzelak, MD
NPI: 1669950671
Total Payments
$915.01
2024 Payments
$227.02
Companies
15
Transactions
44
Medicare Patients
418
Medicare Billing
$32,550
Payment Breakdown by Category
Food & Beverage$915.01 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $915.01 | 44 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $465.97 | 23 | $0 (2024) |
| IDORSIA PHARMACEUTICALS US INC | $122.89 | 1 | $0 (2023) |
| Novo Nordisk Inc | $68.67 | 4 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $50.50 | 3 | $0 (2024) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $42.26 | 3 | $0 (2022) |
| Exact Sciences Corporation | $27.64 | 1 | $0 (2023) |
| Amgen Inc. | $18.70 | 1 | $0 (2024) |
| Xeris Pharmaceuticals, Inc. | $17.09 | 1 | $0 (2024) |
| Abbott Laboratories | $16.81 | 1 | $0 (2023) |
| Bayer HealthCare Pharmaceuticals Inc. | $16.22 | 1 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $227.02 | 11 | ABBVIE INC. ($143.44) |
| 2023 | $443.63 | 17 | ABBVIE INC. ($243.84) |
| 2022 | $186.13 | 12 | ABBVIE INC. ($78.69) |
| 2021 | $58.23 | 4 | Boehringer Ingelheim Pharmaceuticals, Inc. ($17.51) |
All Payment Transactions
44 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $29.72 | General |
| Category: NEUROSCIENCE | ||||||
| 10/30/2024 | Xeris Pharmaceuticals, Inc. | GVOKE HYPOPEN (Drug) | Food and Beverage | In-kind items and services | $17.09 | General |
| Category: Diabetes | ||||||
| 10/02/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $18.70 | General |
| Category: Inflammation | ||||||
| 08/01/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $15.42 | General |
| Category: NEUROSCIENCE | ||||||
| 06/12/2024 | Merck Sharp & Dohme LLC | GARDASIL (Biological), VAXNEUVANCE, GARDASIL 9 | Food and Beverage | In-kind items and services | $13.75 | General |
| Category: VACCINE | ||||||
| 05/16/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $22.94 | General |
| Category: NEUROSCIENCE | ||||||
| 03/20/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $29.86 | General |
| Category: NEUROSCIENCE | ||||||
| 02/21/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $17.14 | General |
| Category: DIABETES | ||||||
| 02/07/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $31.83 | General |
| Category: NEUROSCIENCE | ||||||
| 01/11/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $16.90 | General |
| Category: Obesity | ||||||
| 01/03/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $13.67 | General |
| Category: NEUROSCIENCE | ||||||
| 12/28/2023 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $27.64 | General |
| Category: Oncology | ||||||
| 12/15/2023 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $13.14 | General |
| Category: Obesity | ||||||
| 12/13/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $25.32 | General |
| Category: NEUROSCIENCE | ||||||
| 12/06/2023 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $17.66 | General |
| Category: NEUROSCIENCE | ||||||
| 11/16/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $14.08 | General |
| Category: NEUROSCIENCE | ||||||
| 10/25/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $30.29 | General |
| Category: NEUROSCIENCE | ||||||
| 09/21/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $24.42 | General |
| Category: NEUROSCIENCE | ||||||
| 09/13/2023 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $18.43 | General |
| Category: NEUROSCIENCE | ||||||
| 08/03/2023 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $14.37 | General |
| Category: NEUROSCIENCE | ||||||
| 06/14/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $19.63 | General |
| Category: NEUROSCIENCE | ||||||
| 05/24/2023 | Abbott Laboratories | FREESTYLE LIBRE 2 (Device) | Food and Beverage | In-kind items and services | $16.81 | General |
| Category: Diabetes Care | ||||||
| 05/16/2023 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $17.69 | General |
| Category: NEUROSCIENCE | ||||||
| 05/03/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $23.81 | General |
| Category: NEUROSCIENCE | ||||||
| 03/02/2023 | IDORSIA PHARMACEUTICALS US INC | QUVIVIQ (Drug) | Food and Beverage | In-kind items and services | $122.89 | General |
| Category: INSOMNIA | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 6 | 154 | 212 | $35,124 | $10,706 |
| 2022 | 10 | 216 | 277 | $44,982 | $16,937 |
| 2021 | 2 | 48 | 58 | $9,116 | $4,907 |
Total Patients
418
Total Services
547
Medicare Billing
$32,550
Procedure Codes
18
All Medicare Procedures & Services
18 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 56 | 96 | $17,280 | $4,819 | 27.9% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 32 | 32 | $8,800 | $2,009 | 22.8% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 11 | 25 | $3,175 | $1,444 | 45.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 23 | 27 | $3,645 | $1,013 | 27.8% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 14 | 14 | $1,540 | $935.09 | 60.7% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 18 | 18 | $684.00 | $486.20 | 71.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 67 | 98 | $17,423 | $5,957 | 34.2% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 19 | 19 | $5,138 | $2,150 | 41.8% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 15 | 30 | $5,460 | $2,024 | 37.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 38 | 42 | $5,430 | $1,883 | 34.7% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 12 | 12 | $4,236 | $1,707 | 40.3% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2022 | 17 | 17 | $3,179 | $1,346 | 42.3% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2022 | 11 | 11 | $1,210 | $753.94 | 62.3% |
| 87426 | Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus | Office | 2022 | 14 | 14 | $1,680 | $487.88 | 29.0% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 12 | 12 | $456.00 | $323.28 | 70.9% |
| 87400 | Detection test by immunoassay technique for influenza virus | Office | 2022 | 11 | 22 | $770.00 | $304.88 | 39.6% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 31 | 41 | $7,093 | $3,790 | 53.4% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 17 | 17 | $2,023 | $1,117 | 55.2% |
About Dr. Joseph Grzelak, MD
Dr. Joseph Grzelak, MD is a Student in an Organized Health Care Education/Training Program healthcare provider based in Burlington, Kentucky. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/01/2018. The National Provider Identifier (NPI) number assigned to this provider is 1669950671.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Joseph Grzelak, MD has received a total of $915.01 in payments from pharmaceutical and medical device companies, with $227.02 received in 2024. These payments were reported across 44 transactions from 15 companies. The most common payment nature is "Food and Beverage" ($915.01).
As a Medicare-enrolled provider, Grzelak has provided services to 418 Medicare beneficiaries, totaling 547 services with total Medicare billing of $32,550. Data is available for 3 years (2021–2023), covering 18 distinct procedure/service records.
Ad
Practice Information
- Specialty Student in an Organized Health Care Education/Training Program
- Other Specialties Family Medicine
- Location Burlington, KY
- Active Since 08/01/2018
- Last Updated 07/11/2023
- Taxonomy Code 390200000X
- Entity Type Individual
- NPI Number 1669950671
Products in Payments
- VRAYLAR (Drug) $318.87
- QUVIVIQ (Drug) $122.89
- UBRELVY (Drug) $115.04
- JARDIANCE (Drug) $50.50
- Wegovy (Drug) $49.35
- XIFAXAN (Drug) $42.26
- QULIPTA (Drug) $32.06
- Cologuard Collection Kit (Device) $27.64
- Otezla (Drug) $18.70
- GVOKE HYPOPEN (Drug) $17.09
- FREESTYLE LIBRE 2 (Device) $16.81
- Kerendia (Drug) $16.22
- Livalo (Drug) $14.48
- Vascepa (Drug) $14.40
- GARDASIL (Biological) $13.75
- PreHevbrio (Drug) $13.20
- ENTRESTO (Drug) $12.43
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Student in an Organized Health Care Education/Training Program Doctors in Burlington
Dr. Sergey Leshchinskiy, M.d, M.D
Student in an Organized Health Care Education/Training Program — Payments: $784,522
Student in an Organized Health Care Education/Training Program $784,522
Andrew Goldsmith
Student in an Organized Health Care Education/Training Program — Payments: $82,778
Student in an Organized Health Care Education/Training Program $82,778
Mr. Gurpreet Lamba, M.b.b.s, M.B.B.S
Student in an Organized Health Care Education/Training Program — Payments: $75,278
Student in an Organized Health Care Education/Training Program $75,278
Dr. Michael Callegari, Md, Mba, MD, MBA
Student in an Organized Health Care Education/Training Program — Payments: $52,617
Student in an Organized Health Care Education/Training Program $52,617
Hye Jin Hwang
Student in an Organized Health Care Education/Training Program — Payments: $30,147
Student in an Organized Health Care Education/Training Program $30,147
Meaghan Collins, M.d, M.D
Student in an Organized Health Care Education/Training Program — Payments: $15,691
Student in an Organized Health Care Education/Training Program $15,691